Dr. Bethany Malone has treated a lot of colorectal cancer patients. The youngest, not counting those with genetic conditions, was 19 years old.Colorectal cancer used to be considered a cancer of older ...
Zacks.com on MSN
BMY vs AMGN: Which Biotech Stock Is More Resilient Now?
AMGN edges out its rival with stronger growth estimates, a broad portfolio boost from Horizon, and momentum from key drugs like Repatha and Tezspire.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback